4//SEC Filing
ORAGENICS INC 4
Accession 0000899243-17-017211
$OGENCIK 0001174940operating
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 3:57 PM ET
Size
16.0 KB
Accession
0000899243-17-017211
Insider Transaction Report
Form 4
ORAGENICS INCOGEN.BC
KOSKI FAMILY LP
10% Owner
Transactions
- Award
Non-Employee Director Option (Right to Buy)
2017-06-22+140,000→ 140,000 totalExercise: $0.37From: 2017-06-22Exp: 2027-06-22→ Common Stock (140,000 underlying)
Holdings
- 519,666
Common Stock
- 530,851(indirect: By Trust)
Common Stock
- 1,572,523
Common Stock
- 12,864,822
Common Stock
- 20,000(indirect: By Koski Management, Inc.)
Common Stock
- 1,087,878
Common Stock
Footnotes (8)
- [F1]Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- [F2]Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned directly by Christine L. Koski.
- [F4]Shares owned directly by Robert C. Koski, a director of the Company.
- [F5]Shares owned directly by Thomas L. Koski.
- [F6]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
- [F7]Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (100,000 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (100,000 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (100,000 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (97,666 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
- [F8]Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001174940
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 3:57 PM ET
- Size
- 16.0 KB